UBS AM
CRGX

UBS AM’s CARGO Therapeutics CRGX Stock Holding History

UBS AM’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,773
Closed -$60.1K – 2640
2025
Q1 		$60.1K Sell
14,773
-59
-0.4% -$395 ﹤0.01% 2610
2024
Q4 		$214K Buy
14,832
+3,570
+32% +$64.8K ﹤0.01% 2634
2024
Q3 		$208K Sell
11,262
-1,772
-14% -$31.7K ﹤0.01% 2757
2024
Q2 		$214K Buy
+13,034
New +$248K ﹤0.01% 2751

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return

UBS AM's CRGX Position: Q2 2025 in Review

UBS AM sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 14,773 shares — an estimated $60.1K sold.

UBS AM first reported a position in CRGX in Q2 2024 and held it in 4 quarters. The position peaked at $214K in Q2 2024. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.

  • UBS AM reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
  • UBS AM sold 14,773 CARGO Therapeutics shares in Q2 2025, an estimated $60.1K.
  • UBS AM first reported a position in CARGO Therapeutics in Q2 2024 and held it in 4 quarters.
  • UBS AM's CARGO Therapeutics position peaked at $214K in Q2 2024.
  • 116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.

Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.